Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Reservoir Media | RSVR | Jan 21, 2025 | 8.10 | +2.40 |
ReShape Lifesciences | RSLS | Jan 21, 2025 | 4.53 | +0.22 |
Resideo Technologies | REZI | Jan 21, 2025 | 23.09 | +0.57 |
ResMed | RMD | Jan 21, 2025 | 247.79 | +3.34 |
Resources Connection | RGP | Jan 21, 2025 | 8.69 | +2.24 |
Restaurant Brands International | QSR | Jan 21, 2025 | 60.74 | +0.43 |
Retail Bull 3X Direxion | RETL | Jan 21, 2025 | 9.86 | +4.89 |
Retail ETF Market Vectors | RTH | Jan 21, 2025 | 233.77 | +1.24 |
Retail Opportunity Investments | ROIC | Jan 21, 2025 | 17.41 | -0.23 |
ReTo Eco-Solutions | RETO | Jan 21, 2025 | 0.88 | -3.30 |
Retractable Technologies | RVP | Jan 21, 2025 | 0.81 | +2.72 |
REV Group | REVG | Jan 21, 2025 | 35.58 | +3.28 |
Revance Therapeutics | RVNC | Jan 21, 2025 | 3.67 | -0.27 |
Revelation Biosciences | REVB | Jan 21, 2025 | 0.41 | +3.20 |
Revelyst | GEAR | Jan 21, 2025 | 20.08 | 0.00 |
Revenueshares Largecap | RWL | Jan 21, 2025 | 102.33 | +0.70 |
Revenueshares Midcap | RWK | Jan 21, 2025 | 123.29 | +1.62 |
Revenueshares Smallcap | RWJ | Jan 21, 2025 | 47.73 | +1.62 |
Revenueshares Ultra Dividend Fund | RDIV | Jan 21, 2025 | 49.69 | +1.33 |
Reviva Pharmaceuticals | RVPH | Jan 21, 2025 | 2.00 | +12.99 |
Revolution Medicines | RVMD | Jan 21, 2025 | 40.16 | -0.32 |
Revolve Group A | RVLV | Jan 21, 2025 | 31.00 | +3.26 |
Revvity | RVTY | Jan 21, 2025 | 123.95 | +4.70 |
REX American Resources | REX | Jan 21, 2025 | 41.43 | -0.74 |
Rexford Industrial Realty | REXR | Jan 21, 2025 | 40.59 | +4.08 |
Rexford Industrial Realty B Pref | REXR-B | Jan 21, 2025 | 22.86 | +0.48 |
Rexford Industrial Realty C Pref | REXR-C | Jan 21, 2025 | 21.63 | +0.93 |
Reynolds Consumer Products | REYN | Jan 21, 2025 | 27.41 | +1.18 |
Rezolute | RZLT | Jan 21, 2025 | 4.92 | +1.03 |
Rezolve AI Limited - Ordinary Shares | RZLV | Jan 21, 2025 | 2.86 | +0.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.